CGX Fundamental Analysis - CGRE AG

Fundamental Rating

CGX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 71 industry peers in the Real Estate Management & Development industry. CGX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CGX is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

CGX had negative earnings in the past year.

1.2 Ratios

With a Return On Assets value of -1.22%, CGX perfoms like the industry average, outperforming 41.56% of the companies in the same industry.

CGX's Return On Equity of -1.43% is in line compared to the rest of the industry. CGX outperforms 45.45% of its industry peers.

		Industry Rank	Sector Rank
ROA	-1.22%
ROE	-1.43%
ROIC	N/A

ROA(3y)1.1%

ROA(5y)N/A

ROE(3y)-2.7%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 82.90%, CGX is in the better half of the industry, outperforming 77.92% of the companies in the same industry.

In the last couple of years the Gross Margin of CGX has declined.

The Profit Margin and Operating Margin are not available for CGX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	82.9%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-5.99%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CGX does not have a ROIC to compare to the WACC, probably because it is not profitable.

CGX has about the same amout of shares outstanding than it did 1 year ago.

Compared to 1 year ago, CGX has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 6.54 indicates that CGX is not in any danger for bankruptcy at the moment.

With an excellent Altman-Z score value of 6.54, CGX belongs to the best of the industry, outperforming 98.70% of the companies in the same industry.

A Debt/Equity ratio of 0.15 indicates that CGX is not too dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.15, CGX is in the better half of the industry, outperforming 79.22% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	N/A
Altman-Z	6.54

ROIC/WACCN/A

WACC7.26%

2.3 Liquidity

A Current Ratio of 6.85 indicates that CGX has no problem at all paying its short term obligations.

The Current ratio of CGX (6.85) is better than 90.91% of its industry peers.

CGX has a Quick Ratio of 4.28. This indicates that CGX is financially healthy and has no problem in meeting its short term obligations.

With an excellent Quick ratio value of 4.28, CGX belongs to the best of the industry, outperforming 87.01% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	6.85
Quick Ratio	4.28

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for CGX have decreased strongly by -620.00% in the last year.

Looking at the last year, CGX shows a very strong growth in Revenue. The Revenue has grown by 109.46%.

CGX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.66% yearly.

EPS 1Y (TTM)-620%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-200%

Revenue 1Y (TTM)109.46%

Revenue growth 3Y-7.66%

Revenue growth 5YN/A

Sales Q2Q%169.72%

3.2 Future

The Earnings Per Share is expected to grow by 65.40% on average over the next years. This is a very strong growth

Based on estimates for the next years, CGX will show a very strong growth in Revenue. The Revenue will grow by 496.55% on average per year.

EPS Next Y242.32%

EPS Next 2Y106.14%

EPS Next 3Y65.4%

EPS Next 5YN/A

Revenue Next Year17154.9%

Revenue Next 2Y1538.02%

Revenue Next 3Y496.55%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CGX. In the last year negative earnings were reported.

Based on the Price/Forward Earnings ratio of 26.27, the valuation of CGX can be described as expensive.

Compared to the rest of the industry, the Price/Forward Earnings ratio of CGX is on the same level as its industry peers.

CGX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.79, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	26.27

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

CGX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as CGX's earnings are expected to grow with 65.40% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y106.14%

EPS Next 3Y65.4%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CGX!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

CGRE AG

FRA:CGX (12/5/2025, 7:00:00 PM)

-0.4 (-2.99%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryReal Estate Management & Development

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners1.13%

Inst Owner ChangeN/A

Ins Owners6.37%

Ins Owner ChangeN/A

Market Cap78.00M

Revenue(TTM)208.20K

Net Income(TTM)-730.00K

Analysts45.71

Price Target14.89 (14.54%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)24.84%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	26.27
P/S	374.64
P/FCF	N/A
P/OCF	N/A
P/B	1.52
P/tB	1.52
EV/EBITDA	N/A

EPS(TTM)-0.26

EYN/A

EPS(NY)0.49

Fwd EY3.81%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS0.03

BVpS8.57

TBVpS8.57

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.22%
ROE	-1.43%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	82.9%
FCFM	N/A

ROA(3y)1.1%

ROA(5y)N/A

ROE(3y)-2.7%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-5.99%

GM growth 5YN/A

F-ScoreN/A

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	6.85
Quick Ratio	4.28
Altman-Z	6.54

F-ScoreN/A

WACC7.26%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-620%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-200%

EPS Next Y242.32%

EPS Next 2Y106.14%

EPS Next 3Y65.4%

EPS Next 5YN/A

Revenue 1Y (TTM)109.46%

Revenue growth 3Y-7.66%

Revenue growth 5YN/A

Sales Q2Q%169.72%

Revenue Next Year17154.9%

Revenue Next 2Y1538.02%

Revenue Next 3Y496.55%

Revenue Next 5YN/A

EBIT growth 1Y-422.22%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year21021.4%

EBIT Next 3Y527.67%

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

CGRE AG / CGX.DE FAQ

What is the ChartMill fundamental rating of CGRE AG (CGX.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CGX.DE.

What is the valuation status of CGRE AG (CGX.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to CGRE AG (CGX.DE). This can be considered as Overvalued.

How profitable is CGRE AG (CGX.DE) stock?

CGRE AG (CGX.DE) has a profitability rating of 1 / 10.

Can you provide the financial health for CGX stock?

The financial health rating of CGRE AG (CGX.DE) is 6 / 10.

CGRE AG (CGX.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

CGRE AG / CGX.DE FAQ

What is the ChartMill fundamental rating of CGRE AG (CGX.DE) stock?

What is the valuation status of CGRE AG (CGX.DE) stock?

How profitable is CGRE AG (CGX.DE) stock?

Can you provide the financial health for CGX stock?